Literature DB >> 9806565

Prevention of severe ovarian hyperstimulation by coasting.

M Dhont1, F Van der Straeten, P De Sutter.   

Abstract

OBJECTIVE: To evaluate the efficiency of withholding gonadotropins and deferring the administration of hCG until E2 levels start dropping (coasting) in the prevention of ovarian hyperstimulation syndrome (OHSS) in a high-risk population.
DESIGN: Retrospective case-control study.
SETTING: In vitro fertilization program at a university center. PATIENT(S): The case group consisted of 120 women undergoing ovarian stimulation for IVF who were considered to be at risk for ovarian hyperstimulation (serum E2 levels >2,500 pg/mL or >20 follicles at the time of hCG administration). INTERVENTION(S): Gonadotropin administration was withheld when serum E2 levels exceeded 2,500 pg/mL, and hCG administration was delayed until E2 levels dropped below 2,500 pg/mL. Outcomes were compared with those from 120 matched patients in whom serum E2 levels and the number of follicles at the time of hCG administration were comparable to those at the beginning of coasting (control group). MAIN OUTCOME MEASURE(S): Incidence of moderate and severe OHSS. The number of oocytes retrieved and pregnancy rate (PR) were compared in both groups. RESULT(S): Coasting decreased the incidence of moderate and severe OHSS. The odds ratio of severe OHSS in the coasting group was 0.11 (95% confidence interval 0.01-0.86). Although the number of oocytes was significantly lower in the coasting group (19.7 +/- 0.6 versus 22.1 +/- 0.6), coasting did not affect the PR (37.5% versus 36.7%). CONCLUSION(S): Our study indicates that coasting is an efficient method for reducing the incidence and severity of OHSS without compromising the PR.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806565     DOI: 10.1016/s0015-0282(98)00280-5

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF/ICSI cycles.

Authors:  Yu-Hung Lin; Kok-Min Seow; Bih-Chwen Hsieh; Lee-Wen Huang; Heng-Ju Chen; Shih-Chia Huang; Chih-Yu Chen; Pei-Hsin Chen; Jiann-Loung Hwang; Chi-Ruey Tzeng
Journal:  J Assist Reprod Genet       Date:  2007-07-17       Impact factor: 3.412

2.  Prevention of ovarian hyperstimulation syndrome by early aspiration of small follicles in hyper-responsive patients with polycystic ovaries during assisted reproductive treatment cycles.

Authors:  Oluseye A Oyawoye; Bina Chander; Jocelyn Hunter; Ahmed Abdel Gadir
Journal:  MedGenMed       Date:  2005-08-16

3.  Is Coasting Valuable in All Patients with Any Cause of Infertility?

Authors:  Tahereh Madani; Nadia Jahangiri; Poopak Eftekhari-Yazdi; Mahnaz Ashrafi; Mohammadreza Akhoond
Journal:  Oman Med J       Date:  2016-11

4.  A unique human chorionic gonadotropin antagonist suppresses ovarian hyperstimulation syndrome in rats.

Authors:  Pratibhasri A Vardhana; Martin A Julius; Susan V Pollak; Evan G Lustbader; Rhonda K Trousdale; Joyce W Lustbader
Journal:  Endocrinology       Date:  2009-05-14       Impact factor: 4.736

5.  Prediction of ovarian hyperstimulation syndrome in coasted patients in an IVF/ICSI program.

Authors:  Fatimah Y Aljawoan; Linda P Hunt; Uma D Gordon
Journal:  J Hum Reprod Sci       Date:  2012-01

6.  Sliding scale HCG trigger yields equivalent pregnancy outcomes and reduces ovarian hyperstimulation syndrome: Analysis of 10,427 IVF-ICSI cycles.

Authors:  Vinay Gunnala; Alexis Melnick; Mohamad Irani; David Reichman; Glenn Schattman; Owen Davis; Zev Rosenwaks
Journal:  PLoS One       Date:  2017-04-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.